Accelerated Innovation: The New Challenge From China
Rather than focusing on technological breakthroughs, Chinese companies are finding new ways to innovate that reduce lead times and speed up problem solving. Companies elsewhere should take notice.
Chinese companies are opening up a new front in global competition. It centers on what we call accelerated innovation — that is, reengineering research and development and innovation processes to make new product development dramatically faster and less costly. The new emphasis is unlikely to generate stunning technological breakthroughs, but it allows Chinese competitors to reduce the time it takes to bring innovative products and services to mainstream markets. It also represents a different way of deploying Chinese cost and volume advantages in global competition.
Silicon Valley and other technology hotbeds may be able to match the speed of Chinese innovation in particular sectors such as electronics and Internet-based services. However, what’s distinctive about the strongest Chinese competitors is their capability to combine accelerated innovation with rapid scale-up to high volume at low cost, and to apply these techniques across a wide variety of traditional industries. We saw accelerated innovation being deployed in Chinese industries ranging from pharmaceuticals, telecommunications and information technology to medical and industrial equipment, consumer electronics and e-business. Although it may not impact companies that are consistently able to deliver breakthrough innovations, it presents real threats and opportunities to many mainstream competitors.
The Push to Accelerate Innovation
We spent three years researching the way Chinese companies are accelerating R&D and innovation thanks to the low cost and abundant supply of Chinese engineers. (See “About the Research.”) We found that Chinese companies are industrializing innovation to improve speed and cost by applying lessons from production lines, pushing the boundaries of simultaneous engineering to cut the lead times for new product development, rapidly incorporating user feedback into new designs to drive down the learning curve faster and restructuring their organizations to speed up problem solving. These developments have potentially huge implications for how companies should think about global competition and whether they need to rethink and reengineer their established innovation and product development processes.
1. J. Ribbens, “Simultaneous Engineering for New Product Development: Manufacturing Applications” (New York: Wiley, 2000).
2. P.N. Golder and G.J. Tellis, “Pioneer Advantage: Marketing Logic or Marketing Legend?,” Journal of Marketing Research 30, no. 2, (May 1993): 158-170; C.C. Markides and P.A. Geroski, “Fast Second: How Smart Companies Bypass Radical Innovation to Enter and Dominate New Markets” (London: John Wiley, 2004); O. Shenkar, “Copycats: How Smart Companies Use Imitation to Gain a Strategic Edge” (Boston: Harvard Business Press, 2010).
3. P. Barwise and S. Meehan, “Innovating Beyond the Familiar,” European Business Review, May 20, 2012, www.europeanbusinessreview.com.
4. P. Engardio and M. Ihlwan, “Samsung’s ‘Sashimi Theory’ of Success,” BusinessWeek, June 10, 2003, www.businessweek.com.
5. J.M. Utterback and W.J. Abernathy, “A Dynamic Model of Product and Process Innovation,” Omega 3, no. 6 (December 1975): 639-656.
6. C. Neumeyer, “China’s Great Leap Forward in Patents,” IP Watchdog, April 4, 2013, www.ipwatchdog.com.
7. J. Teo, “Innovating in China’s Pharma Market: An Interview with AstraZeneca’s Head of R&D in Asia and Emerging Markets,” McKinsey Quarterly, February 2012 , www.mckinsey.com.
8. L. Burkitt, “PepsiCo to Cut Ribbon on China R&D Facility,” Wall Street Journal, November 12, 2012.
9. “Pharmaron Forms Strategic Partnership With Astrazeneca to Accelerate Drug Discovery,” press release, October 14, 2012, www.pharmaron.com.